engage:BDR partners with publisher management platform FatTail

Published 22-JUN-2020 16:05 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

engage:BDR (ASX:EN1; EN1O) has forged a new strategic programmatic partnership with FatTail, a leading publisher management platform.

Founded in 2001, FatTail is a leading provider of cloud software that automates and controls the entire advertising lifecycle for publishers.

The group’s goal is to see professional journalism endure by helping publishers of great content flourish.

In achieving this, the group delivers innovative solutions to complex business challenges that drive revenue, operational efficiency, agility and control for their customers.

AdBook+ is the culmination of nearly 15 years of continuous development, and today offers a complete set of ad operations, sales and financial tools that enable publishers to run their entire advertising business from within FatTail's cloud-based SaaS platform.

The company's integrations with other best-of-breed technology partners allow publishers to use AdBook+ as a true one-product solution for optimally managing the sale and fulfillment of guaranteed ad inventory across all media products and sales channels.

Provides EN1 with access to thousands of top-tier publishers

Through an openRTB Programmatic Guaranteed integration into its publisher management platform, AdBook+, FatTail will provide EN1 direct incremental access to thousands of top-tier publishers that the company does not currently work with.

These include Forbes, the Financial Times Conde Nast, Hearst, Scripps and Triad Digital.

EN1 has growing demand across its buyers for CTV and OTT inventory, and FatTail’s publishers represent considerable inventory in these areas today.

FatTail and EN1 share a common mission in that both platforms were developed to provide publishers with monetisation alternatives to the heavyweights, with Google being the main target.

Google’s publisher ad serving solutions (DFP) have been industry standards since display advertising began.

This ad serving technology locked Google into having the first look at publisher ad inventories and blocked publishers from integrating their own programmatic demand.

Both companies reduce publisher revenue dependencies on Google

EN1’s technology solution for publishers enables agnostic demand, reducing publisher revenue dependencies on Google.

FatTail’s solution is consistent with this mantra, allowing its publishers to directly connect their own demand partners (such as EN1) to their supply through header bidding and openRTB integrations, bypassing Google’s ad servers and demand stack.

At the same time though, this also offers the inventory in a true auction to Google in parallel as opposed to having Google represent it to the ecosystem.

This concept clearly disrupts Google’s display advertising strategy and its reach into top-tier publishers by increasing publisher yield, performance and campaign quality.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X